Recent News for CDNA - CareDx, Inc.

Date Title
Jun 24 Hedge Funds Aren’t Crazy About CareDx, Inc. (CDNA) Anymore
Jun 22 New Kidney360 Publication Highlights CareDx’s AlloSure is Differentiated as the dd-cfDNA Test of Choice
Jun 18 CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 18 FDA Accepts Letter of Intent for iBox Scoring System as a Surrogate Endpoint in Pharmaceutical Clinical Trials
Jun 15 CareDx Announces Closing of Public Offering of Common Stock
Jun 11 CareDx prices equity offering at $32
Jun 11 CareDx Announces Pricing of Public Offering of Common Stock
Jun 10 CareDx files for mixed shelf
Jun 9 CareDx seeks to raise $100M
Jun 9 CareDx Announces Proposed Public Offering of Common Stock
Jun 9 Seven Bridges Selected by CareDx to Advance Its Transplant Care Solutions
Jun 8 CareDx Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting
Jun 4 CareDx to Participate at the Goldman Sachs Global Healthcare Conference
May 28 CareDx to Present at the Jefferies Virtual Healthcare Conference
May 27 CareDx Presents the Latest AlloSure Data in Virtual Meetings
May 15 CareDx transplant donor match test CE Mark'd
May 15 CareDx's AlloSeq Tx 17 Awarded CE Mark Approval
May 14 CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
May 7 CareDx Brings the Transplant Patient Community Together
May 5 CareDx Collaborates with Weill Cornell Medicine to Lead the Development and Commercialization of UroMap
May 2 Here's Why We're Not At All Concerned With CareDx's (NASDAQ:CDNA) Cash Burn Situation
May 1 CareDx, Inc 2020 Q1 - Results - Earnings Call Presentation
May 1 CareDx Inc (CDNA) Q1 2020 Earnings Call Transcript
May 1 Edited Transcript of CDNA earnings conference call or presentation 30-Apr-20 8:30pm GMT
May 1 CareDx, Inc (CDNA) CEO Peter Maag on Q1 2020 Results - Earnings Call Transcript

Back to the Main CDNA Page...